Cosmas Giallourakis

Cosmas Giallourakis, MD, serves as the Interim President and Chief Scientific Officer at Stylus Medicine since September 2022, having a background that includes roles as a Venture Partner at RA Capital Management, L.P. since November 2021 and Co-Founder/Founding CEO of Circ Bio, which was acquired by Orbital Therapeutics in September 2022. Prior experience includes a Venture Capitalist/Entrepreneur in Residence position at Third Rock Ventures, and a Director role at Takeda, overseeing Cell and Gene Therapy for Gastroenterology Drug Discovery. Academic contributions as an Assistant Professor of Medicine at Harvard Medical School included research on genomic approaches to epigenetic and post-transcriptional RNA modifications, with publications in renowned journals. Additionally, Cosmas Giallourakis was a faculty member at Massachusetts General Hospital, focusing on clinical practice in autoimmune gastrointestinal illnesses. Academic credentials include a Bachelor of Science in Physics from the Massachusetts Institute of Technology and a Doctor of Medicine from Rutgers New Jersey Medical School.